What next after the collapse of Silicon Valley Bank?

What next after the collapse of Silicon Valley Bank?

During the early stages of the pandemic, Silicon Valley Bank assisted medtech startups in growing and pivoting as testing demand increased and municipalities partnered with diagnostic companies. It helped life science companies that didn't have market fit because their products were so novel. Traditional banks were more risk-averse and didn't understand emerging technology as well as SVB. This raises the question of how many biotech companies will fund their innovations.

While Silicon Valley Bank, the bank chosen by roughly half of all funded U.S. startups, failed to adequately hedge for the combination of higher interest rates and increased withdrawals, blaming this error on depositors is incorrect. They were not involved in the financial planning and, like most of us, base their decisions on an institution's reputation, track record, service, and product offerings.